Accuracy of clinical diagnosis of Parkinson disease

Neurology

Volumn 86, Issue 6, 2016, Pages 566-576

  Rizzo, Giovanni ^a,b   Copetti, Massimiliano ^b   Arcuti, Simona ^a   Martino, Davide ^c   Fontana, Andrea ^b   Logroscino, Giancarlo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DISEASE DURATION; ESSENTIAL TREMOR; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; GOLD STANDARD; HUMAN; META ANALYSIS; MOTOR DYSFUNCTION; NEUROPATHOLOGY; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SYSTEMATIC REVIEW; TREMOR; BAYES THEOREM; BRAIN; EARLY DIAGNOSIS; PATHOPHYSIOLOGY;

BIOLOGICAL MARKER;

BAYES THEOREM; BIOMARKERS; BRAIN; EARLY DIAGNOSIS; HUMANS; PARKINSON DISEASE;

EID: 84957837117     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002350     Document Type: Article

References (48)

1. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
2. Caslake R, Moore JN, Gordon JC, et al. Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J Neurol Neurosurg Psychiatry 2008;79: 1202-1207.
3. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-148.
4. Jellinger KA, Attems J. Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm 2015; 122:505-521.
5. National Collaborating Centre for Chronic Conditions (UK). Parkinson's Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. London: Royal College of Physicians; 2006.
6. Berardelli A, Wenning GK, Antonini A, et al. EFNS/MDS-ES/ENS recommendations for the diagnosis of Parkinson's disease. Eur J Neurol 2013;20:16-34.
7. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
8. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
9. Verde PE. Meta-analysis of diagnostic test data: a bivariate Bayesian modeling approach. Stat Med 2010;29: 3088-3102.
10. Spiegelhalter DJ, Thomas A, Best N. WinBUGS, Version 1.4, Upgraded to 1.4.1, User Manual. Cambridge: MRC Biostatistics Unit; 2004.
11. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism: a prospective study. Can J Neurol Sci 1991;18:275-278.
12. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
13. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42:1142-1146.
14. Litvan I, MacIntyre A, Goetz CG, et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 1998;55:969-978.
15. Jankovic J, Rajput AH, McDermott MP, Perl DP. The evolution of diagnosis in early Parkinson disease: Parkinson Study Group. Arch Neurol 2000;57: 369-372.
16. Jellinger KA. The pathology of Parkinson's disease. Adv Neurol 2001;86:55-72.
17. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001;57:1497-1499.
18. Lees AJ, Katzenschlager R, Head J, Ben-Shlomo Y. Tenyear follow-up of three different initial treatments in denovo PD: a randomized trial. Neurology 2001;57: 1687-1694.
19. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125: 861-870.
20. Stoffers D, Booij J, Bosscher L, Winogrodzka A, Wolters EC, Berendse HW. Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease. Eur J Nucl Med Mol Imaging 2005;32:689-695.
21. Jellinger KA. Morphological substrates of parkinsonism with and without dementia: a retrospective clinicopathological study. J Neural Transm Suppl 2007:91-104.
22. Horvath J, Burkhard PR, Bouras C, Kövari E. Etiologies of parkinsonism in a century-long autopsy-based cohort. Brain Pathol 2013;23:28-33.
23. Joutsa J, Gardberg M, Roÿttä M, Kaasinen V. Diagnostic accuracy of parkinsonism syndromes by general neurologists. Parkinsonism Relat Disord 2014;20:840-844.
24. Marek K, Seibyl J, Eberly S, et al. Longitudinal follow-up of SWEDD subjects in the PRECEPT Study. Neurology 2014;82:1791-1797.
25. Adler CH, Beach TG, Hentz JG, et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology 2014;83:406-412.
26. Marshall VL, Reininger CB, Marquardt M, et al. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT. Mov Disord 2009;24:500-508.
27. Bajaj NP, Gontu V, Birchall J, et al. Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry 2010;81: 1223-1228.
28. Meara J, Bhowmick BK, Hobson P. Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing 1999;28:99-102.
29. Schrag A, Ben-Shlomo Y, Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community? J Neurol Neurosurg Psychiatry 2002;73:529-534.
30. Bower JH, Dickson DW, Taylor L, et al. Clinical correlates of the pathology underlying parkinsonism: a population perspective. Mov Disord 2002;17:910-916.
31. Simpson BS, Clarke CE. Retrospective evaluation of the diagnostic accuracy of Parkinsonism in a UK community based movement disorders clinic. Parkinsonism Relat Disord 2013;19:461-462.
32. Alves G, Müller B, Herlofson K, et al. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 2009; 80:851-857.
33. Linder J, Stenlund H, Forsgren L. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study. Mov Disord 2010;25:341-348.
34. Winter Y, Bezdolnyy Y, Katunina E, et al. Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study. Mov Disord 2010;25:349-356.
35. Caslake R, Taylor K, Scott N, et al. Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in northeast Scotland: the PINE study. Parkinsonism Relat Disord 2013;19:515-521.
36. Duncan GW, Khoo TK, Coleman SY, et al. The incidence of Parkinson's disease in the North-East of England. Age Ageing 2014;43:257-263.
37. Gaenslen A, Unmuth B, Godau J, et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 2008;7:417-424.
38. Maraganore DM, Anderson DW, Bower JH, et al. Autopsy patterns for Parkinson's disease and related disorders in Olmsted County, Minnesota. Neurology 1999; 53:1342-1344.
39. Uitti RJ, Calne DB, Dickson DW, Wszolek ZK. Is the neuropathological "gold standard" diagnosis dead? Implications of clinicopathological findings in an autosomal dominant neurodegenerative disorder. Parkinsonism Relat Disord 2004;10:461-463.
40. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.
41. McKeith I. Dementia with Lewy bodies and Parkinson's disease with dementia: where two worlds collide. Pract Neurol 2007;7:374-382.
42. Huang Y, Halliday G. Can we clinically diagnose dementia with Lewy bodies yet? Transl Neurodegener 2013;2:4.
43. Kovacs GG, Milenkovic I, Wöhrer A, et al. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol 2013;126:365-384.
44. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001;57:456-462.
45. Iranzo A, Lomenã F, Stockner H, et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 2010;9: 1070-1077.
46. Mahlknecht P, Iranzo A, Högl B, et al. Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. Neurology 2015;84:654-658.
47. Berg D, Behnke S, Seppi K, et al. Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease. Mov Disord 2013;28:216-219.
48. Jennings D, Siderowf A, Stern M, et al. Imaging prodromal parkinson disease: the Parkinson associated risk syndrome study. Neurology 2014;83:1739-1746.